Pedro Corpuz

Pedro Corpuz has a diverse and extensive work experience in the pharmaceutical and biotechnology industry. Pedro recently served as the Director of Biomarker Operations at Alumis since April 2022. Prior to that, they worked as a Senior Manager at Arcus Biosciences from March 2021 to April 2022. From April 2020 to March 2021, they held the position of Senior Clinical Trial Manager (Biomarker Operations) at Gilead Sciences, where they managed clinical biosample and biomarker activities for various programs. Pedro also worked as a Project Lead at Forty Seven Inc. from December 2019 to March 2021, managing clinical biosample activities for multiple clinical trials. Before that, they served as a Clinical Trial Manager at Five Prime Therapeutics, Inc. Pedro has also held positions at Genentech, where they worked as a Senior Project Support Coordinator and Site Innovation Group Lead. Pedro began their career at Genentech as a Project Support Coordinator and Systems Support PDG Global.

Pedro Corpuz obtained a Bachelor of Science degree from the University of Puget Sound.